PCR Testing Providers Reel in Mega Profits During COVID-19 Years

A health care worker administers a PCR test on a woman in the intensive care unit of the Rafic Hariri University Hospital in the Lebanese capital Beirut, on Jan. 5, 2021. Joseph Eid/AFP via Getty Images

The latest annual reports from three major pathology firms—that provided large-scale PCR testing during the pandemic—reveal bumper profits from the COVID-19 years.

Global pathology provider, Sonic Healthcare reeled in a record $1.46 billion (US$950 million) net profit—an 11 percent increase on the previous year—while its revenue was also up seven percent to $9.3 billion.